{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:17:21Z","timestamp":1794665841846,"version":"4.9.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41574-024-01046-z","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T11:03:13Z","timestamp":1729767793000},"page":"92-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["The epidemiology of type 1 diabetes mellitus in older adults"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2471-2523","authenticated-orcid":false,"given":"Dunya","family":"Tomic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-8630","authenticated-orcid":false,"given":"Jessica L.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-3717","authenticated-orcid":false,"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6187-2203","authenticated-orcid":false,"given":"Jonathan E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-6096","authenticated-orcid":false,"given":"Dianna J.","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"1046_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69\u201382 (2014).","journal-title":"Lancet"},{"key":"1046_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","volume":"5","author":"A Weisman","year":"2017","unstructured":"Weisman, A., Bai, J. W., Cardinez, M., Kramer, C. K. & Perkins, B. A. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 5, 501\u2013512 (2017).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1046_CR3","doi-asserted-by":"publisher","first-page":"h3234","DOI":"10.1136\/bmj.h3234","volume":"350","author":"I Steineck","year":"2015","unstructured":"Steineck, I. et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ 350, h3234 (2015).","journal-title":"BMJ"},{"key":"1046_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","volume":"10","author":"J Schofield","year":"2019","unstructured":"Schofield, J., Ho, J. & Soran, H. Cardiovascular risk in type 1 diabetes mellitus. Diabetes Ther. 10, 773\u2013789 (2019).","journal-title":"Diabetes Ther."},{"key":"1046_CR5","doi-asserted-by":"publisher","first-page":"110580","DOI":"10.1016\/j.diabres.2023.110580","volume":"198","author":"M Arffman","year":"2023","unstructured":"Arffman, M., Hakkarainen, P., Keskim\u00e4ki, I., Oksanen, T. & Sund, R. Long-term and recent trends in survival and life expectancy for people with type 1 diabetes in Finland. Diabetes Res. Clin. Pract. 198, 110580 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1210\/jc.2005-1623","volume":"91","author":"RD Leslie","year":"2006","unstructured":"Leslie, R. D., Williams, R. & Pozzilli, P. Clinical review: type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J. Clin. Endocrinol. Metab. 91, 1654\u20131659 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1046_CR7","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.2337\/db11-1625","volume":"61","author":"RG Miller","year":"2012","unstructured":"Miller, R. G., Secrest, A. M., Sharma, R. K., Songer, T. J. & Orchard, T. J. Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes 61, 2987\u20132992 (2012).","journal-title":"Diabetes"},{"key":"1046_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/1932296819894974","volume":"15","author":"AL Carlson","year":"2021","unstructured":"Carlson, A. L. et al. Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM study. J. Diabetes Sci. Technol. 15, 582\u2013592 (2021).","journal-title":"J. Diabetes Sci. Technol."},{"key":"1046_CR9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2337\/dc17-1955","volume":"41","author":"G Musen","year":"2018","unstructured":"Musen, G. et al. Cognitive function deficits associated with long-duration type 1 diabetes and vascular complications. Diabetes Care 41, 1749\u20131756 (2018).","journal-title":"Diabetes Care"},{"key":"1046_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cger.2014.08.022","volume":"31","author":"M Park","year":"2015","unstructured":"Park, M. & Reynolds, C. F. 3rd Depression among older adults with diabetes mellitus. Clin. Geriatr. Med. 31, 117\u2013137 (2015).","journal-title":"Clin. Geriatr. Med."},{"key":"1046_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1210\/clinem\/dgz153","volume":"105","author":"E Halper-Stromberg","year":"2020","unstructured":"Halper-Stromberg, E. et al. Bone mineral density across the lifespan in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 105, 746\u2013753 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1046_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.diabres.2008.07.022","volume":"82","author":"M Thunander","year":"2008","unstructured":"Thunander, M. et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res. Clin. Pract. 82, 247\u2013255 (2008). This was the first study to describe incidence of T1DM in older adults that exceeded that in all age groups, including in children.","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032916","volume":"10","author":"KA Gajewska","year":"2020","unstructured":"Gajewska, K. A., Biesma, R., Sreenan, S. & Bennett, K. Prevalence and incidence of type 1 diabetes in Ireland: a retrospective cross-sectional study using a national pharmacy claims data from 2016. BMJ Open 10, e032916 (2020). This study followed from Thunander et al. (ref. 12) to also report the highest incidence of T1DM in older adults out of all age groups, strengthening the evidence for a possible second incidence peak after age 70 years.","journal-title":"BMJ Open"},{"key":"1046_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001071","volume":"8","author":"B Carstensen","year":"2020","unstructured":"Carstensen, B., R\u00f8nn, P. F. & J\u00f8rgensen, M. E. Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996-2016. BMJ Open Diabetes Res. Care 8, e001071 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1046_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0958-6","volume":"15","author":"MAM Rogers","year":"2017","unstructured":"Rogers, M. A. M., Kim, C., Banerjee, T. & Lee, J. M. Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. BMC Med. 15, 199 (2017).","journal-title":"BMC Med."},{"key":"1046_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.endinu.2022.11.005","volume":"70","author":"R Rodr\u00edguez Escobedo","year":"2023","unstructured":"Rodr\u00edguez Escobedo, R., Delgado \u00c1lvarez, E. & Men\u00e9ndez Torre, E. L. Incidence of type 1 diabetes mellitus in Asturias (Spain) between 2011 and 2020. Endocrinol. Diabetes Nutr. 70, 189\u2013195 (2023).","journal-title":"Endocrinol. Diabetes Nutr."},{"key":"1046_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1591-y","volume":"15","author":"PA Diaz-Valencia","year":"2015","unstructured":"Diaz-Valencia, P. A., Bougn\u00e8res, P. & Valleron, A.-J. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 15, 255 (2015).","journal-title":"BMC Public Health"},{"key":"1046_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001262","volume":"8","author":"Y Nishioka","year":"2020","unstructured":"Nishioka, Y. et al. Incidence and seasonality of type 1 diabetes: a population-based 3-year cohort study using the National Database in Japan. BMJ Open Diabetes Res. Care 8, e001262 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1046_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003052","volume":"17","author":"AOY Luk","year":"2020","unstructured":"Luk, A. O. Y. et al. Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort study. PLoS Med. 17, e1003052 (2020).","journal-title":"PLoS Med."},{"key":"1046_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086172","volume":"9","author":"WH Lin","year":"2014","unstructured":"Lin, W. H. et al. Incidence of and mortality from Type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PLoS One 9, e86172 (2014).","journal-title":"PLoS One"},{"key":"1046_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jfma.2012.09.014","volume":"111","author":"YD Jiang","year":"2012","unstructured":"Jiang, Y. D., Chang, C. H., Tai, T. Y., Chen, J. F. & Chuang, L. M. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. J. Formos. Med. Assoc. 111, 599\u2013604 (2012).","journal-title":"J. Formos. Med. Assoc."},{"key":"1046_CR22","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2337\/dc21-0342","volume":"44","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Incidence of type 1 diabetes may be underestimated in the Chinese population: evidence from 21.7 million people between 2007 and 2017. Diabetes Care 44, 2503\u20132509 (2021).","journal-title":"Diabetes Care"},{"key":"1046_CR23","doi-asserted-by":"publisher","first-page":"j5295","DOI":"10.1136\/bmj.j5295","volume":"360","author":"J Weng","year":"2018","unstructured":"Weng, J. et al. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ 360, j5295 (2018).","journal-title":"BMJ"},{"key":"1046_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/1520-7560(2000)9999:9999<::AID-DMRR164>3.0.CO;2-M","volume":"17","author":"Y Park","year":"2001","unstructured":"Park, Y. & Eisenbarth, G. S. Genetic susceptibility factors of type 1 diabetes in Asians. Diabetes Metab. Res. Rev. 17, 2\u201311 (2001).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1046_CR25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/pds.4377","volume":"27","author":"EB Schroeder","year":"2018","unstructured":"Schroeder, E. B., Donahoo, W. T., Goodrich, G. K. & Raebel, M. A. Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record data. Pharmacoepidemiol. Drug Saf. 27, 1053\u20131059 (2018).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"1046_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14, 88\u201398 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1046_CR27","unstructured":"Australian Bureau of Statistics. Diabetes. Reference Period 2022 https:\/\/www.abs.gov.au\/statistics\/health\/health-conditions-and-risks\/diabetes\/latest-release (2023)."},{"key":"1046_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/diaclin.34.1.25","volume":"34","author":"PM Trief","year":"2016","unstructured":"Trief, P. M., Cibula, D., Rodriguez, E., Akel, B. & Weinstock, R. S. Incorrect insulin administration: a problem that warrants attention. Clin. Diabetes 34, 25\u201333 (2016).","journal-title":"Clin. Diabetes"},{"key":"1046_CR29","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.2337\/dc14-0096","volume":"37","author":"JL Harding","year":"2014","unstructured":"Harding, J. L. et al. Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997-2010. Diabetes Care 37, 2579\u20132586 (2014).","journal-title":"Diabetes Care"},{"key":"1046_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14449","volume":"38","author":"E Foteinopoulou","year":"2021","unstructured":"Foteinopoulou, E. et al. Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes. Diabet. Med. 38, e14449 (2021).","journal-title":"Diabet. Med."},{"key":"1046_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.eprac.2023.01.004","volume":"29","author":"S Iqbal","year":"2023","unstructured":"Iqbal, S., Jayyab, A. A., Alrashdi, A. M. & Revert\u00e9-Villarroya, S. The predictive ability of C-peptide in distinguishing type 1 diabetes from type 2 diabetes: a systematic review and meta-analysis. Endocr. Pract. 29, 379\u2013387 (2023).","journal-title":"Endocr. Pract."},{"key":"1046_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.15585\/mmwr.mm6712a2","volume":"67","author":"KM Bullard","year":"2018","unstructured":"Bullard, K. M. et al. Prevalence of diagnosed diabetes in adults by diabetes type \u2014 United States, 2016. MMWR Morb. Mortal. Wkly Rep. 67, 359\u2013361 (2018).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1046_CR33","doi-asserted-by":"publisher","first-page":"k1497","DOI":"10.1136\/bmj.k1497","volume":"362","author":"G Xu","year":"2018","unstructured":"Xu, G. et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ 362, k1497 (2018).","journal-title":"BMJ"},{"key":"1046_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/EDE.0b013e31829ef01a","volume":"24","author":"A Menke","year":"2013","unstructured":"Menke, A. et al. The prevalence of type 1 diabetes in the United States. Epidemiol 24, 773\u2013774 (2013).","journal-title":"Epidemiol"},{"key":"1046_CR35","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/dme.14239","volume":"37","author":"RAS Campbell","year":"2020","unstructured":"Campbell, R. A. S. et al. Socio-economic status and mortality in people with type 1 diabetes in Scotland 2006-2015: a retrospective cohort study. Diabet. Med. 37, 2081\u20132088 (2020).","journal-title":"Diabet. Med."},{"key":"1046_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/medicina43030030","volume":"43","author":"R Ostrauskas","year":"2007","unstructured":"Ostrauskas, R. The prevalence of type 1 diabetes mellitus among adolescents and adults in Lithuania during 1991-2004. Medicina 43, 242\u2013250 (2007).","journal-title":"Medicina"},{"key":"1046_CR37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S2213-8587(22)00252-2","volume":"10","author":"D Tomic","year":"2022","unstructured":"Tomic, D. et al. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes Endocrinol. 10, 795\u2013803 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1046_CR38","unstructured":"National Diabetes Services Scheme. Type 1 Diabetes as at 30 June 2024 https:\/\/www.ndss.com.au\/wp-content\/uploads\/Diabetes-Type-1-1.pdf (2024)."},{"key":"1046_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2014.16425","volume":"313","author":"SJ Livingstone","year":"2015","unstructured":"Livingstone, S. J. et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 313, 37\u201344 (2015).","journal-title":"JAMA"},{"key":"1046_CR40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-005-0120-4","volume":"49","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu, S. S. et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 49, 660\u2013666 (2006).","journal-title":"Diabetologia"},{"key":"1046_CR41","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2337\/dc15-2308","volume":"39","author":"JL Harding","year":"2016","unstructured":"Harding, J. L., Shaw, J. E., Peeters, A., Davidson, S. & Magliano, D. J. Age-specific trends from 2000-2011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people. Diabetes Care 39, 1018\u20131026 (2016).","journal-title":"Diabetes Care"},{"key":"1046_CR42","doi-asserted-by":"publisher","first-page":"107943","DOI":"10.1016\/j.diabres.2019.107943","volume":"160","author":"M Thunander","year":"2020","unstructured":"Thunander, M., Lindgren, A., Petersson, C., Landin-Olsson, M. & Holmberg, S. Standard mortality rates and years of life lost for serologically defined adult-onset type 1 and type 2 diabetes \u2014 a fifteen year follow-up. Diabetes Res. Clin. Pract. 160, 107943 (2020).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR43","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s00125-022-05659-9","volume":"65","author":"PLD Ruiz","year":"2022","unstructured":"Ruiz, P. L. D. et al. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts. Diabetologia 65, 964\u2013972 (2022). This multi-country analysis highlighted the increased mortality in older adults with T1DM compared with the general population, reporting standardized mortality ratios greater than 1 in all older adult age groups.","journal-title":"Diabetologia"},{"key":"1046_CR44","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00125-015-3857-4","volume":"59","author":"L Huo","year":"2016","unstructured":"Huo, L., Harding, J. L., Peeters, A., Shaw, J. E. & Magliano, D. J. Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study. Diabetologia 59, 1177\u20131185 (2016).","journal-title":"Diabetologia"},{"key":"1046_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001065","volume":"9","author":"B Carstensen","year":"2021","unstructured":"Carstensen, B., R\u00f8nn, P. F. & J\u00f8rgensen, M. E. Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996-2016. BMJ Open Diabetes Res. Care 9, e001065 (2021).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1046_CR46","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","volume":"387","author":"F Pociot","year":"2016","unstructured":"Pociot, F. & Lernmark, \u00c5. Genetic risk factors for type 1 diabetes. Lancet 387, 2331\u20132339 (2016).","journal-title":"Lancet"},{"key":"1046_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2337\/diab.44.1.125","volume":"44","author":"CB Sanjeevi","year":"1995","unstructured":"Sanjeevi, C. B. et al. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. Diabetes 44, 125\u2013131 (1995).","journal-title":"Diabetes"},{"key":"1046_CR48","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"Erlich, H. et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57, 1084\u20131092 (2008).","journal-title":"Diabetes"},{"key":"1046_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","volume":"11","author":"JA Noble","year":"2011","unstructured":"Noble, J. A. & Valdes, A. M. Genetics of the HLA region in the prediction of type 1 diabetes. Curr. Diab. Rep. 11, 533\u2013542 (2011).","journal-title":"Curr. Diab. Rep."},{"key":"1046_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98460-4","volume":"11","author":"B Haris","year":"2021","unstructured":"Haris, B. et al. Clinical features, epidemiology, autoantibody status, HLA haplotypes and genetic mechanisms of type 1 diabetes mellitus among children in Qatar. Sci. Rep. 11, 18887 (2021).","journal-title":"Sci. Rep."},{"key":"1046_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1034\/j.1399-0004.1999.560608.x","volume":"56","author":"MZ Haider","year":"1999","unstructured":"Haider, M. Z., Shaltout, A., Alsaeid, K., Qabazard, M. & Dorman, J. Prevalence of human leukocyte antigen DQA1 and DQB1 alleles in Kuwaiti Arab children with type 1 diabetes mellitus. Clin. Genet. 56, 450\u2013456 (1999).","journal-title":"Clin. Genet."},{"key":"1046_CR52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/dmrr.2609","volume":"31","author":"MI El-Amir","year":"2015","unstructured":"El-Amir, M. I. et al. Risk genes and autoantibodies in Egyptian children with type 1 diabetes \u2014 low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype. Diabetes Metab. Res. Rev. 31, 287\u2013294 (2015).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"1046_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","volume":"64","author":"JA Noble","year":"2015","unstructured":"Noble, J. A. Immunogenetics of type 1 diabetes: a comprehensive review. J. Autoimmun. 64, 101\u2013112 (2015).","journal-title":"J. Autoimmun."},{"key":"1046_CR54","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.2337\/db11-0364","volume":"60","author":"JM Howson","year":"2011","unstructured":"Howson, J. M., Rosinger, S., Smyth, D. J., Boehm, B. O. & Todd, J. A. Genetic analysis of adult-onset autoimmune diabetes. Diabetes 60, 2645\u20132653 (2011).","journal-title":"Diabetes"},{"key":"1046_CR55","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s001250051626","volume":"44","author":"MJ Redondo","year":"2001","unstructured":"Redondo, M. J. et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44, 354\u2013362 (2001).","journal-title":"Diabetologia"},{"key":"1046_CR56","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2337\/dc19-0986","volume":"43","author":"R Mishra","year":"2020","unstructured":"Mishra, R. et al. Genetic discrimination between LADA and childhood-onset type 1 diabetes within the MHC. Diabetes Care 43, 418\u2013425 (2020).","journal-title":"Diabetes Care"},{"key":"1046_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031586","volume":"9","author":"A Lynam","year":"2019","unstructured":"Lynam, A. et al. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years. BMJ Open 9, e031586 (2019).","journal-title":"BMJ Open"},{"key":"1046_CR58","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1007\/s00125-021-05476-6","volume":"64","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z. et al. HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetes. Diabetologia 64, 2026\u20132036 (2021).","journal-title":"Diabetologia"},{"key":"1046_CR59","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00125-023-06004-4","volume":"66","author":"NJ Thomas","year":"2023","unstructured":"Thomas, N. J. & Jones, A. G. The challenges of identifying and studying type 1 diabetes in adults. Diabetologia 66, 2200\u20132212 (2023). This 2023 review described the challenges of diagnosing T1DM in older adults.","journal-title":"Diabetologia"},{"key":"1046_CR60","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/dc18-2023","volume":"42","author":"M Zhu","year":"2019","unstructured":"Zhu, M. et al. Identification of novel T1D risk loci and their association with age and islet function at diagnosis in autoantibody-positive T1D individuals: based on a two-stage genome-wide association study. Diabetes Care 42, 1414\u20131421 (2019).","journal-title":"Diabetes Care"},{"key":"1046_CR61","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s00125-017-4308-1","volume":"60","author":"SE Regnell","year":"2017","unstructured":"Regnell, S. E. & Lernmark, \u00c5. Early prediction of autoimmune (type 1) diabetes. Diabetologia 60, 1370\u20131381 (2017).","journal-title":"Diabetologia"},{"key":"1046_CR62","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1210\/jc.2012-2037","volume":"97","author":"S Zampetti","year":"2012","unstructured":"Zampetti, S. et al. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). J. Clin. Endocrinol. Metab. 97, 3759\u20133765 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1046_CR63","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1007\/s00125-020-05229-x","volume":"63","author":"SA Balcha","year":"2020","unstructured":"Balcha, S. A. et al. Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia. Diabetologia 63, 2158\u20132168 (2020).","journal-title":"Diabetologia"},{"key":"1046_CR64","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2337\/db12-0207","volume":"62","author":"Z Zhou","year":"2013","unstructured":"Zhou, Z. et al. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes 62, 543\u2013550 (2013).","journal-title":"Diabetes"},{"key":"1046_CR65","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.2337\/dc19-0475","volume":"42","author":"BM Brooks-Worrell","year":"2019","unstructured":"Brooks-Worrell, B. M. & Palmer, J. P. Setting the stage for islet autoimmunity in type 2 diabetes: obesity-associated chronic systemic inflammation and endoplasmic reticulum (ER) stress. Diabetes Care 42, 2338\u20132346 (2019).","journal-title":"Diabetes Care"},{"key":"1046_CR66","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1111\/dom.14785","volume":"24","author":"E Maddaloni","year":"2022","unstructured":"Maddaloni, E. et al. C-peptide determination in the diagnosis of type of diabetes and its management: a clinical perspective. Diabetes Obes. Metab. 24, 1912\u20131926 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"1046_CR67","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.0705894104","volume":"104","author":"JM Wenzlau","year":"2007","unstructured":"Wenzlau, J. M. et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl Acad. Sci. USA 104, 17040\u201317045 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1046_CR68","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2337\/dc10-1903","volume":"34","author":"DM Tridgell","year":"2011","unstructured":"Tridgell, D. M., Spiekerman, C., Wang, R. S. & Greenbaum, C. J. Interaction of onset and duration of diabetes on the percent of GAD and IA-2 antibody-positive subjects in the type 1 diabetes genetics consortium database. Diabetes Care 34, 988\u2013993 (2011).","journal-title":"Diabetes Care"},{"key":"1046_CR69","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2337\/dc14-1952","volume":"38","author":"AK Davis","year":"2015","unstructured":"Davis, A. K. et al. Prevalence of detectable C-peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care 38, 476\u2013481 (2015).","journal-title":"Diabetes Care"},{"key":"1046_CR70","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/dme.13142","volume":"33","author":"SV Hope","year":"2016","unstructured":"Hope, S. V. et al. Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic. Diabet. Med. 33, 1554\u20131558 (2016).","journal-title":"Diabet. Med."},{"key":"1046_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00125-018-4722-z","volume":"62","author":"JM Wentworth","year":"2019","unstructured":"Wentworth, J. M. et al. Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables. Diabetologia 62, 33\u201340 (2019).","journal-title":"Diabetologia"},{"key":"1046_CR72","doi-asserted-by":"publisher","first-page":"110859","DOI":"10.1016\/j.diabres.2023.110859","volume":"203","author":"SF Sajjadi","year":"2023","unstructured":"Sajjadi, S. F. et al. Algorithms to define diabetes type using data from administrative databases: a systematic review of the evidence. Diabetes Res. Clin. Pract. 203, 110859 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR73","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2337\/diab.42.2.359","volume":"42","author":"T Tuomi","year":"1993","unstructured":"Tuomi, T. et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42, 359\u2013362 (1993).","journal-title":"Diabetes"},{"key":"1046_CR74","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2337\/dc20-2834","volume":"44","author":"AG Jones","year":"2021","unstructured":"Jones, A. G., McDonald, T. J., Shields, B. M., Hagopian, W. & Hattersley, A. T. Latent autoimmune diabetes of adults (LADA) is likely to represent a mixed population of autoimmune (type 1) and nonautoimmune (type 2) diabetes. Diabetes Care 44, 1243\u20131251 (2021).","journal-title":"Diabetes Care"},{"key":"1046_CR75","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1007\/s00125-005-1960-7","volume":"48","author":"S Fourlanos","year":"2005","unstructured":"Fourlanos, S. et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48, 2206\u20132212 (2005).","journal-title":"Diabetologia"},{"key":"1046_CR76","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/dc07-1308","volume":"31","author":"S Brophy","year":"2008","unstructured":"Brophy, S. et al. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care 31, 439\u2013441 (2008).","journal-title":"Diabetes Care"},{"key":"1046_CR77","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2337\/dc12-0931","volume":"36","author":"MI Hawa","year":"2013","unstructured":"Hawa, M. I. et al. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7. Diabetes Care 36, 908\u2013913 (2013).","journal-title":"Diabetes Care"},{"key":"1046_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131837","volume":"10","author":"E Maddaloni","year":"2015","unstructured":"Maddaloni, E. et al. Latent autoimmune diabetes in adults in the United Arab Emirates: clinical features and factors related to insulin-requirement. PLoS One 10, e0131837 (2015).","journal-title":"PLoS One"},{"key":"1046_CR79","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00592-015-0799-8","volume":"52","author":"Y Xiang","year":"2015","unstructured":"Xiang, Y. et al. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5. Acta Diabetol. 52, 1121\u20131127 (2015).","journal-title":"Acta Diabetol."},{"key":"1046_CR80","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2337\/dc06-1696","volume":"30","author":"R Buzzetti","year":"2007","unstructured":"Buzzetti, R. et al. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30, 932\u2013938 (2007).","journal-title":"Diabetes Care"},{"key":"1046_CR81","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.diabres.2008.01.024","volume":"80","author":"S Murao","year":"2008","unstructured":"Murao, S. et al. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA) \u2014 a 5-year follow-up of the Ehime study. Diabetes Res. Clin. Pract. 80, 114\u2013121 (2008).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR82","doi-asserted-by":"publisher","first-page":"580202","DOI":"10.5402\/2012\/580202","volume":"2012","author":"PP Brahmkshatriya","year":"2012","unstructured":"Brahmkshatriya, P. P., Mehta, A. A., Saboo, B. D. & Goyal, R. K. Characteristics and prevalence of latent autoimmune diabetes in adults (LADA). ISRN Pharmacol. 2012, 580202 (2012).","journal-title":"ISRN Pharmacol."},{"key":"1046_CR83","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.2337\/dc07-0718","volume":"30","author":"S Carlsson","year":"2007","unstructured":"Carlsson, S., Midthjell, K. & Grill, V. Influence of family history of diabetes on incidence and prevalence of latent autoimmune diabetes of the adult: results from the Nord-Tr\u00f8ndelag Health Study. Diabetes Care 30, 3040\u20133045 (2007).","journal-title":"Diabetes Care"},{"key":"1046_CR84","first-page":"1728","volume":"116","author":"X Li","year":"2003","unstructured":"Li, X., Yang, L., Zhou, Z., Huang, G. & Yan, X. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults. Chin. Med. J. 116, 1728\u20131732 (2003).","journal-title":"Chin. Med. J."},{"key":"1046_CR85","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1464-5491.1994.tb00275.x","volume":"11","author":"PZ Zimmet","year":"1994","unstructured":"Zimmet, P. Z. et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet. Med. 11, 299\u2013303 (1994).","journal-title":"Diabet. Med."},{"key":"1046_CR86","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0140-6736(97)03062-6","volume":"350","author":"R Turner","year":"1997","unstructured":"Turner, R. et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350, 1288\u20131293 (1997).","journal-title":"Lancet"},{"key":"1046_CR87","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1210\/jc.2009-1120","volume":"94","author":"RG Naik","year":"2009","unstructured":"Naik, R. G., Brooks-Worrell, B. M. & Palmer, J. P. Latent autoimmune diabetes in adults. J. Clin. Endocrinol. Metab. 94, 4635\u20134644 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1046_CR88","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/diabetes.54.suppl_2.S62","volume":"54","author":"JP Palmer","year":"2005","unstructured":"Palmer, J. P., Hampe, C. S., Chiu, H., Goel, A. & Brooks-Worrell, B. M. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 54, S62\u2013S67 (2005).","journal-title":"Diabetes"},{"key":"1046_CR89","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2014-000076","volume":"3","author":"EP S\u00f8rgjerd","year":"2015","unstructured":"S\u00f8rgjerd, E. P. et al. Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study. BMJ Open Diabetes Res. Care 3, e000076 (2015).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"1046_CR90","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2337\/dc14-2426","volume":"38","author":"AK Steck","year":"2015","unstructured":"Steck, A. K. et al. Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: the environmental determinants of diabetes in the young (TEDDY). Diabetes Care 38, 808\u2013813 (2015).","journal-title":"Diabetes Care"},{"key":"1046_CR91","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.2337\/db14-1693","volume":"64","author":"AJ Williams","year":"2015","unstructured":"Williams, A. J. et al. Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of gad autoantibody assays for type 1 diabetes. Diabetes 64, 3239\u20133246 (2015).","journal-title":"Diabetes"},{"key":"1046_CR92","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/dme.12850","volume":"32","author":"WM Kuhtreiber","year":"2015","unstructured":"Kuhtreiber, W. M. et al. Low levels of C-peptide have clinical significance for established type 1 diabetes. Diabet. Med. 32, 1346\u20131353 (2015).","journal-title":"Diabet. Med."},{"key":"1046_CR93","doi-asserted-by":"publisher","first-page":"765","DOI":"10.12669\/pjms.36.4.1531","volume":"36","author":"A Fawwad","year":"2020","unstructured":"Fawwad, A. et al. Relationship of C-peptide levels to duration of Type 1 diabetes \u2014 a study from Sindh, Pakistan. Pak. J. Med. Sci. 36, 765\u2013769 (2020).","journal-title":"Pak. J. Med. Sci."},{"key":"1046_CR94","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/pedi.13209","volume":"22","author":"TAM Ibrahim","year":"2021","unstructured":"Ibrahim, T. A. M. et al. Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Sudan. Pediatr. Diabetes 22, 749\u2013757 (2021).","journal-title":"Pediatr. Diabetes"},{"key":"1046_CR95","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/pedi.13411","volume":"23","author":"S Besan\u00e7on","year":"2022","unstructured":"Besan\u00e7on, S. et al. Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Mali. Pediatr. Diabetes 23, 1552\u20131559 (2022).","journal-title":"Pediatr. Diabetes"},{"key":"1046_CR96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.diabres.2019.01.023","volume":"149","author":"A Fawwad","year":"2019","unstructured":"Fawwad, A. et al. Clinical features, biochemistry and HLA-DRB1 status in youth-onset type 1 diabetes in Pakistan. Diabetes Res. Clin. Pract. 149, 9\u201317 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR97","doi-asserted-by":"publisher","first-page":"107894","DOI":"10.1016\/j.diabres.2019.107894","volume":"158","author":"B Zabeen","year":"2019","unstructured":"Zabeen, B. et al. Clinical features, biochemistry and HLA-DRB1 status in children and adolescents with diabetes in Dhaka, Bangladesh. Diabetes Res. Clin. Pract. 158, 107894 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR98","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.diabres.2018.09.009","volume":"144","author":"GA Ahmadov","year":"2018","unstructured":"Ahmadov, G. A. et al. Epidemiology of childhood-onset type 1 diabetes in Azerbaijan: incidence, clinical features, biochemistry, and HLA-DRB1 status. Diabetes Res. Clin. Pract. 144, 252\u2013259 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1046_CR99","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist, E. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 6, 361\u2013369 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1046_CR100","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00125-016-3914-7","volume":"59","author":"D Petrie","year":"2016","unstructured":"Petrie, D. et al. Recent trends in life expectancy for people with type 1 diabetes in Sweden. Diabetologia 59, 1167\u20131176 (2016).","journal-title":"Diabetologia"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01046-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01046-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01046-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T01:01:34Z","timestamp":1736989294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-01046-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-01046-z","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"26 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}